NCT00151463View on ClinicalTrials.gov

QEQ Treatment Responsiveness Evaluation Study

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Conditions
Impotence
Interventions
DRUG

sildenafil citrate

Trial Locations (9)

Unknown

Pfizer Investigational Site, Bondi Junction

Pfizer Investigational Site, Darlinghurst

Pfizer Investigational Site, St Leonards

Pfizer Investigational Site, Spring Hill

Pfizer Investigational Site, Adelaide

Pfizer Investigational Site, Clayton

Pfizer Investigational Site, Malvern

Pfizer Investigational Site, Mentone

Pfizer Investigational Site, Nedlands

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00151463 - QEQ Treatment Responsiveness Evaluation Study | Biotech Hunter | Biotech Hunter